These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26901148)

  • 1. Colonic leishmaniasis in a patient with HIV: a case report.
    Soria López E; Olalla Sierra J; Del Arco Jiménez A; Pereda Salguero T; Abitei C; de la Torre Lima J
    Rev Esp Enferm Dig; 2016 Dec; 108(12):838-840. PubMed ID: 26901148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapsing visceral leishmaniasis in a HIV-1 infected patient with advanced disease.
    Standaert D; Laurent F; Jonckheere S; Scheiff JM; Vandercam B; Yombi JC
    Acta Clin Belg; 2013; 68(2):124-7. PubMed ID: 23967722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Visceral leishmaniasis with small intestine and colon involvement in a patient with HIV infection].
    Diego Mediavilla J; Omar M; Jiménez-Alonso J; Miranda C; Aliaga L
    Enferm Infecc Microbiol Clin; 1995; 13(6):377-8. PubMed ID: 7654839
    [No Abstract]   [Full Text] [Related]  

  • 4. Post-kala-azar dermal Leishmaniasis and uveitis in an HIV-positive patient.
    Ramos A; Cruz I; Muñez E; Salas C; Fernández A; Alvarez-Espejo T
    Infection; 2008 Mar; 36(2):184-6. PubMed ID: 18327683
    [No Abstract]   [Full Text] [Related]  

  • 5. An unwelcome synergy: leishmaniasis and HIV.
    Colasanti J; Altamirano J; Espinoza L
    Am J Med; 2013 Feb; 126(2):114-6. PubMed ID: 23331437
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe.
    Rihl M; Stoll M; Ulbricht K; Bange FC; Schmidt RE
    J Infect; 2006 Jul; 53(1):e25-7. PubMed ID: 16274744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration.
    Manfredi R; Marinacci G; Calza L; Passarini B
    Int J Antimicrob Agents; 2008 Jun; 31(6):590-2. PubMed ID: 18456464
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil.
    Daher EF; Fonseca PP; Gerhard ES; Leitão TM; Silva Júnior GB
    J Parasitol; 2009 Jun; 95(3):652-5. PubMed ID: 19642802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lingual leishmaniasis complicating visceral disease.
    Mazumder SA; Pandey S; Brewer SC; Baselski VS; Weina PJ; Land MA; Fleckenstein JM
    J Travel Med; 2010; 17(3):212-4. PubMed ID: 20536896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute liver failure due to visceral leishmaniasis in Barcelona: a case report.
    Martinez de Narvajas I; Díaz A; Bassegoda O; Carpio A; Fuster C; Valls ME; Alvarez-Martínez MJ; García-Vidal C; Soriano A; Martínez JA; Ambrosioni J
    BMC Infect Dis; 2019 Oct; 19(1):874. PubMed ID: 31640598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Options for Visceral Leishmaniasis and HIV Coinfection.
    Monge-Maillo B; López-Vélez R
    AIDS Rev; 2016; 18(1):32-43. PubMed ID: 26936761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonic leishmaniasis followed by liver transplantation.
    Araujo SA; Nascentes Queiroz TC; Demas Alvares Cabral MM
    Am J Trop Med Hyg; 2010 Aug; 83(2):209. PubMed ID: 20682856
    [No Abstract]   [Full Text] [Related]  

  • 14. Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.
    Laguna F; Videla S; Jiménez-Mejías ME; Sirera G; Torre-Cisneros J; Ribera E; Prados D; Clotet B; Sust M; López-Vélez R; Alvar J;
    J Antimicrob Chemother; 2003 Sep; 52(3):464-8. PubMed ID: 12888588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diarrhea due to visceral leishmaniasis in a liver transplant recipient].
    Vargas Acosta AM; Belchí Segura E; Martinez Caselles A; Baños Madrid R; Pons Miñano JA; Parrilla Paricio P
    Gastroenterol Hepatol; 2013 Apr; 36(4):271-3. PubMed ID: 23453560
    [No Abstract]   [Full Text] [Related]  

  • 16. [Visceral leishmaniasis in patient with HIV infection].
    Olea P; Pinilla J
    Rev Chilena Infectol; 2013 Apr; 30(2):216-20. PubMed ID: 23677161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmaniasis.
    Herwaldt BL
    Lancet; 1999 Oct; 354(9185):1191-9. PubMed ID: 10513726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of post-kala-azar dermal leishmaniasis in AmBisome treated visceral leishmaniasis: a possible challenge to elimination program in India.
    Das VN; Pandey K; Singh D; Forwood C; Lal CS; Das P
    J Postgrad Med; 2013; 59(3):226-8. PubMed ID: 24029204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
    Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
    Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine.
    Kumar D; Ramesh V; Verma S; Ramam M; Salotra P
    Ann Trop Med Parasitol; 2009 Dec; 103(8):727-30. PubMed ID: 20030997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.